Skip to main content
Free trial
Company record · Arlon
Belgian companySituation normaleAssociation sans but lucratif

FONDS DE PROMOTION MEDICAL DES CLINIQUES DU SUD LUXEMBOURG

Enterprise number
0866.832.481
VAT number
BE0866832481
Registered office
Rue des Déportés 137, 6700 Arlon
See the 9 companies at this address
Incorporated on
18 August 2004
Official sources·CBE·NBB: Central Balance Sheet Office·Belgian Official Gazette·Map
Members only
Health score
Show the scoreLog in
Latest financial year
2025
m04-f model
Size
Not published
Workforce not declared
Equity
€1.5M
Financial year 2025
Net result
€35.4K
Financial year 2025

Profile

Official information from the CBE (FPS Economy).

FONDS DE PROMOTION MEDICAL DES CLINIQUES DU SUD LUXEMBOURG is a Belgian company (Association sans but lucratif) whose registered office is established at 6700 Arlon. Its main activity falls under “Autres activités auxiliaires de services financiers nca, hors assurance et caisses de retraite” (NACE 66199).

Legal form
Association sans but lucratif
Legal situation
Situation normale
Date of incorporation
18 August 2004
Main activity (NACE)
66199Autres activités auxiliaires de services financiers nca, hors assurance et caisses de retraite

Company names

Official names in several languages: legal name, trade name, abbreviation.

Abbreviation
  • FPM-CSL

Secondary activities

3 additional NACE codes declared.

Anti-money-laundering (AML) compliance

Is this activity subject to the Belgian anti-money-laundering obligations? An indicative assessment based on the declared NACE code.

Obliged entityFinancial or credit institution

Given its declared activity (“Autres activités auxiliaires de services financiers nca, hors assurance et caisses de retraite”), FONDS DE PROMOTION MEDICAL DES CLINIQUES DU SUD LUXEMBOURG belongs to a profession expressly covered by Belgian anti-money-laundering law.

Credit institutions, lenders, leasing and factoring companies, investment firms and fund managers are obliged entities.

Applicable obligations
  • Identification and verification of the client's identity (KYC)
  • Identification of the ultimate beneficial owners (UBO register)
  • Assessment of money-laundering and terrorist-financing risks
  • Ongoing diligence and monitoring of transactions
  • Reporting suspicions to the CTIF
  • Retention of the documents and appointment of an AMLCO
Who is subject to AML obligations?AML transaction monitoringThe complete guide to AML compliance in Belgium

Legal basis: art. 5, §1, 4° and following of the Act of 18 September 2017.

General information based on the declared NACE activity code; it is not legal advice. Whether the obligations actually apply depends on the activity effectively carried out.

Your risk analysis on this company

AML Company ran FONDS DE PROMOTION MEDICAL DES CLINIQUES DU SUD LUXEMBOURG through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Finances & financial health

Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).

Zone Altman
Grade
Computed on
Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2025€1,484,223€35,415

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
91%
Financial year 2025

Equity / balance sheet total

Liquidity
229,07 x
Financial year 2025

Current assets / debts due within one year

Net margin
2,7%
Financial year 2025

Result for the year / turnover

Operating margin
2,5%
Financial year 2025

Operating result / turnover

Long-term debt
-

This year's filing does not carry the item the calculation needs.

Debts due after one year / balance sheet total

Return on equity
2,4%
Financial year 2025

Result for the year / equity

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (1)▾
Financial yearFilingFiling typeModelSource
01/01/2025 → 31/12/202515/09/2026Initialm04-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Health score and detailed factors

The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.

Unlock

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

What the FONDS DE PROMOTION MEDICAL DES CLINIQUES DU SUD LUXEMBOURG record does not say

Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.

Is FONDS DE PROMOTION MEDICAL DES CLINIQUES DU SUD LUXEMBOURG subject to anti-money-laundering obligations in Belgium?
Yes, on the basis of the activity code declared in the register (Financial or credit institution, art. 5, §1, 4° and following of the Act of 18 September 2017). Credit institutions, lenders, leasing and factoring companies, investment firms and fund managers are obliged entities. FONDS DE PROMOTION MEDICAL DES CLINIQUES DU SUD LUXEMBOURG must therefore identify its clients and their beneficial owners, monitor its transactions and report its suspicions to the CTIF-CFI. An indicative verdict, to be checked against the activity actually carried out.
Did FONDS DE PROMOTION MEDICAL DES CLINIQUES DU SUD LUXEMBOURG file its annual accounts on time?
No. FONDS DE PROMOTION MEDICAL DES CLINIQUES DU SUD LUXEMBOURG filed its latest annual accounts with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 15 September 2026, 46 days after 31 July 2026. Article 3:10 of the Code of Companies and Associations requires filing at the latest seven months after the financial year closes. A late filing is a signal to document before entering a business relationship.

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
8 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2026
    1. 15 September 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m04-fFiled accounts2026-00512854
    2. 27 January 2026Appointments · ResignationsView the notice26013452
  2. 2025
    1. 23 July 2025Appointments · ResignationsView the notice25094140
  3. 2021
    1. 18 March 2021Appointments · ResignationsView the notice21035062
  4. 2014
    1. 22 April 2014Articles of association · Appointments · ResignationsView the notice14085969
    2. 24 March 2014Articles of associationView the notice14065979
  5. 2011
    1. 25 February 2011Appointments · ResignationsView the notice11031290
  6. 2004
    1. 26 August 2004IncorporationView the notice04124365

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
Unlock AI insightsSee the plans

Similar companies

Same business sector and geographic area.

Verset Investment & Consulting

0779.498.631
6700 Arlon

de fundering

0407.592.416
9000 Gent

Uitwisselingscentrum en verrekening

0414.509.011
1210 Saint-Josse-ten-Noode

SYLVA

0410.645.936
9000 Gent

CLICREDIT

0789.407.279
6700 Arlon

MOCOGEST

0435.581.369
7090 Braine-le-Comte

JPM U.S. EQUITY FUND

0453.934.363
L-2338 LUXEMBOURG

Agent de banque et d'assurances Grand Sud

0466.444.195
6700 Arlon

Anguille en Nechelput

0400.371.755
1755 Pajottegem
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

Create an account

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, audience-measurement cookies (hosted in the EU) to improve our services. Learn more.